Target Name: MIR7975
NCBI ID: G102466872
Review Report on MIR7975 Target / Biomarker Content of Review Report on MIR7975 Target / Biomarker
MIR7975
Other Name(s): microRNA 7975 | MicroRNA 7975 | hsa-miR-7975 | hsa-mir-7975

MicroRNA 7975: A Potential Drug Target and Biomarker

MicroRNA 7975 (miRNA 7975) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments.

miRNA 7975 is a small RNA molecule that contains about 20-22nt of sequence. It is typically synthesized in the cytoplasm of eukaryotic cells and functions as a negative regulator of gene expression. miRNA 7975 is expressed in various tissues and cell types, including blood cells, tissues, and organs, making it a potential biomarker for disease.

One of the key features of miRNA 7975 is its specificity for its target genes. It is known to interact with the protein known as HIPK3, which is a key regulator of cell cycle progression and apoptosis. When miRNA 7975 binds to HIPK3, it can inhibit the activity of HIPK3 and prevent it from binding to its target genes. This interaction between miRNA 7975 and HIPK3 makes it a potential drug target for diseases that are characterized by disruptions in the cell cycle or apoptosis.

Another feature of miRNA 7975 is its ability to target gene expression in a specific tissue or cell type. For example, studies have shown that miRNA 7975 is expressed in the brain and that it is involved in the regulation of neuronal excitability. This makes it a potential biomarker for neurological diseases, such as Alzheimer's and Parkinson's.

In addition to its potential drug target and biomarker properties, miRNA 7975 also has important roles in the development and progression of various diseases. For example, studies have shown that miRNA 7975 is downregulated in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that targeting miRNA 7975 may be a promising strategy for the development of new treatments for these cancers.

Furthermore, miRNA 7975 has also been shown to have a positive impact on the body's immune system. It has been shown to regulate the production of immune cells in various tissues and to play a role in the immune response to infection. This suggests that miRNA 7975 may be a potential target for treatments that aim to enhance the body's immune system.

In conclusion, miRNA 7975 is a microRNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and function make it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand the role of miRNA 7975 in disease and to develop effective treatments.

Protein Name: MicroRNA 7975

The "MIR7975 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR7975 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A | MIR99AHG | MIR99B | MIRLET7 | MIRLET7A1 | MIRLET7A2 | MIRLET7A3 | MIRLET7B | MIRLET7BHG | MIRLET7C | MIRLET7D | MIRLET7E | MIRLET7F1 | MIRLET7F2 | MIRLET7G | MIRLET7I | MIS12 | MIS12 complex | MIS18A | MIS18A-AS1 | MIS18BP1 | MISFA | MISP | MISP3